Type
Declared sexual-health compound analysis
$122.50
12 analyses
Single-compound, combination and screening options for submitted sexual-health category samples.
Targeted analysis of declared pharmaceutical compounds and selected multi-active formulations.
Type
Declared sexual-health compound analysis
$122.50
Sexual health
Blind PDE5 Inhibitor ScreeningScreening for common PDE5 inhibitor targets in a submitted sample.
Type
Blind PDE5 screening
From $192.50
Type
Declared sexual-health compound analysis
$111.30
Sexual health
Extended Sexual Health Compound ScreeningExtended screening for selected sexual-health category compounds.
Type
Extended screening
From $244.30
Type
Declared sexual-health compound analysis
$104.30
Sexual health
Sildenafil and Dapoxetine Blend AnalysisTargeted analytical evaluation of a submitted Sildenafil and Dapoxetine Blend sample.
Type
Two-compound combination
$164.50
Sexual health
Sildenafil and Tadalafil Blend AnalysisTargeted analytical evaluation of a submitted Sildenafil and Tadalafil Blend sample.
Type
Two-compound combination
$157.50
Type
Declared sexual-health compound analysis
$108.50
Sexual health
Tadalafil and Dapoxetine Blend AnalysisTargeted analytical evaluation of a submitted Tadalafil and Dapoxetine Blend sample.
Type
Two-compound combination
$167.30
Type
Declared sexual-health compound analysis
$129.50
Type
Declared sexual-health compound analysis
$115.50
Sexual health
Vardenafil and Dapoxetine Blend AnalysisTargeted analytical evaluation of a submitted Vardenafil and Dapoxetine Blend sample.
Type
Two-compound combination
$174.30